Innealta Capital’s Orthofix Medical OFIX Stock Holding History

Innealta Capital’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3	Closed	-$40	–	1183
2024 Q2	$40	Buy	+3	New	+$41	﹤0.01%	1762

Other funds holding OFIX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

ECM

Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BCM

Boone Capital Management Atlanta, Georgia $326M AUM 86.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JIC

Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return

Innealta Capital's OFIX Position: Q3 2024 in Review

Innealta Capital sold out of Orthofix Medical (OFIX) in Q3 2024, closing a stake of 3 shares — an estimated $40 sold.

Innealta Capital first reported a position in OFIX in Q2 2024 and held it in 1 quarter. The position peaked at $40 in Q2 2024. 149 funds tracked by Wall St. Rank hold OFIX as of Q3 2024.

Innealta Capital reported no remaining Orthofix Medical position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 3 Orthofix Medical shares in Q3 2024, an estimated $40.
Innealta Capital first reported a position in Orthofix Medical in Q2 2024 and held it in 1 quarter.
Innealta Capital's Orthofix Medical position peaked at $40 in Q2 2024.
149 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.